Schaeffer's Top Stock Picks for '25

Nektar Therapeutics Stock on Track for Worst Day Since '04

NKTR stock is now at risk for bearish brokerage attention

Jun 4, 2018 at 9:52 AM
facebook X logo linkedin


Shares of Nektar Therapeutics (NASDAQ:NKTR) have plunged 30.8% to trade at $62.50 -- pacing for their worst day since August 2004 -- after early data from the company's experimental cancer treatment, NKTR-214, with Bristol-Myers Squibb's (BMY) Opdivo failed to meet Wall Street's expectations. Specifically, the response rate fell 50% once 14 additional patients were enrolled in the study, bringing the total number of participants to 27.

Heading into today's trading, NKTR stock had recently bounced from the $75 region after pulling back from its mid-March record high north of $111.36 -- a neighborhood that's home to a 38.2% Fibonacci retracement of the stock's August through March surge, and 140-day moving average. However, the shares are now trading at their lowest point since January, clinging to a positive year-to-date return.

More losses could be ahead should analysts issue downgrades and/or price-target cuts. Of the 10 analysts covering Nektar Therapeutics stock, nine maintain a "strong buy" rating. Plus, the average 12-month price target of $101.56 stands at a 63% premium to NKTR's current price.

Short sellers would certainly welcome more downside. While the security is on the short-sale restricted (SSR) list through tomorrow's trading, short interest jumped 14% in the two most recent reporting periods to 11.69 million shares -- the most since early November.
 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?